ASCO Abstracts

May 19, 2014
By Applied Clinical Trials Editors

Abstracts related to the conduct of clinical trials, not the actual trials results, from ASCO can be found under the category Health Services Research. Those are then broken down into four areas--

Following is a list of abstracts submitted to ASCO for either presentation at the event or for online only for topics related to clinical trials.


Access to Children’s Oncology Group Phase I clinical trials: Racial/ethnic dissimilarities in participation


Accrual of adolescents and young adults with cancer to eligible clinical trials: A report from the NCIC Clinical Trials Group (NCIC-CTG)


Discussions about clinical trials among patients with lung and colorectal cancer


Equity of access: Consent interpretation program at Princess Margaret Cancer Centre (PM) in Canada


Exclusion of patients with prior cancers from clinical trials: Is this justified?


FDA breakthrough therapy designation of oncology products: The first-year experience


Media reporting of practice-changing clinical trials in oncology: A North American perspective


Social media use amongst oncologists: Results of a national physician survey


Why is it so difficult to enroll patients in clinical trials?


Are new drugs more expensive than old ones? Trends in the benefit-adjusted launch prices of anticancer drugs, 1995-2013


Avoided cost in chemotherapy drugs by patient inclusion in clinical trials


Developing a predictive model for cancer clinical trial accrual



How much is the pharmaceutical industry's cost of capital for clinical research of novel drugs?


Hispanic accrual on randomized cancer clinical trials: A call to arms


Impact of prior cancer on eligibility for lung cancer clinical trials


A randomized, controlled study comparing NCI’s original and revised informed consent templates


A tool to help research programs exceed the minimum standards of conducting clinical research


A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer


An analysis of cancer-specific Twitter conversations among physicians in 2013


Are manufacturers targeting smaller patient populations and are they being rewarded for it?


Are preclinical research findings replicable: An empirical analysis based on EpoR studies in cancer


Audio visual recording of informed consent: Novel mandatory regulatory compliance for clinical trials in India


Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials


Comparison of results between the first and updated reports of phase III clinical trials (RCTs)


Data quality in clinical trials


Development of a patient preference assessment tool for cancer patients considering phase I research


Development of a patient-reported outcome (PRO) measure for assessing non-small cell lung cancer (NSCLC) symptoms in clinical trials: Interim report from the PRO Consortium’s NSCLC Working Group (WG)


Drug-company–sponsored lectures and physicians' prescribing patterns


Impact of National Cancer Institute (NCI)-mandated scientific review on protocol development and content


Impact of the NCI Community Cancer Centers Program (NCCCP) on clinical trial (CT) activities in a community cancer center in rural Nebraska


Improving cancer clinical trial accrual in Ontario, Canada: The clinical trials infrastructure fund (CTIF) experience


Improving the patient (pt) experience through physician engagement


Mobile solution for clinical research documentation


NCI pilot intervention program to assist accrual for challenging late-phase clinical trials


Relationship between type of therapeutic intervention and funding source in randomized clinical trials (RCTs) in oncology


The clinical trial assessment of infrastructure matrix tool (CT AIM) to improve the quality of research conduct in the community


The road to assessing clinical trial-associated workload


Which formats for communicating patient-reported outcomes (PROs) work best?